HCID 17749758, compound → HCID 59170220, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:12][N:11]=[CH:10][C:9]=2[C:13]([OH:15])=O)=[CH:4][CH:3]=1.Cl.Cl.Cl.[NH:19]1[CH2:23][CH2:22][CH:21]([C:24]2[CH:29]=[N:28][CH:27]=[CH:26][N:25]=2)[CH2:20]1>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[O:12][N:11]=[CH:10][C:9]=2[C:13]([N:19]2[CH2:23][CH2:22][CH:21]([C:24]3[CH:29]=[N:28][CH:27]=[CH:26][N:25]=3)[CH2:20]2)=[O:15])=[CH:6][CH:7]=1Participants
3
Procedure
The title compound was prepared from 5-(4-methylphenyl)isoxazole-4-carboxylic acid (10.2 mg, 0.050 mmol) and 2-pyrrolidin-3-yl-pyrazine trihydrochloride (15.5 mg, 0.060 mmol) as described in synthetic method B and thereafter purified by preparative HPLC method B to give a solid (6.0 mg). Calcd for C19H18N4O2: 334.1430, found 334.1426.
Workup
- custompurified by preparative HPLC method B
Sources & evidence
- ORD record
- ord-62d7ac83b28c46bf8bf4527bf860a96d
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07666888B2
Reaction notes
Loading…